Is controversy about 'transfer factor therapy' nearing an end?
Nearly 30-years after Lawrencefirst described 'transfer factor' the therapeutic value of dialysable leukocyte extracts is now being examined in adequately designed trials. The evidence of its efficacy in certain patients in certain circumstances is unmistakable.